General Information of the Protein
Protein ID
PT06034
Protein Name
Myelin-associated glycoprotein
Secondarily
Protein Name
Siglec-4a
Gene Name
MAG
Sequence
MIFLATLPLFWIMISASRGGHWGAWMPSTISAFEGTCVSIPCRFDFPDELRPAVVHGVWYFNSPYPKNYPPVVFKSRTQVVHESFQGRSRLLGDLGLRNCTLLLSTLSPELGGKYYFRGDLGGYNQYTFSEHSVLDIVNTPNIVVPPEVVAGTEVEVSCMVPDNCPELRPELSWLGHEGLGEPTVLGRLREDEGTWVQVSLLHFVPTREANGHRLGCQAAFPNTTLQFEGYASLDVKYPPVIVEMNSSVEAIEGSHVSLLCGADSNPPPLLTWMRDGMVLREAVAKSLYLDLEEVTPGEDGVYACLAENAYGQDNRTVELSVMYAPWKPTVNGTVVAVEGETVSILCSTQSNPDPILTIFKEKQILATVIYESQLQLELPAVTPEDDGEYWCVAENQYGQRATAFNLSVEFAPIILLESHCAAARDTVQCLCVVKSNPEPSVAFELPSRNVTVNETEREFVYSERSGLLLTSILTIRGQAQAPPRVICTSRNLYGTQSLELPFQGAHRLMWAKIGPVGAVVAFAILIAIVCYITQTRRKKNVTESSSFSGGDNPHVLYSPEFRISGAPDKYESEKQRLGSERRLLGLRGESPELDLSYSHSDLGKRPTKDSYTLTEELAEYAEIRVK
    Show/Hide
Organism
Mus musculus, Mouse
Protein Classification
Adhesion
Function
Adhesion molecule that mediates interactions between myelinating cells and neurons by binding to neuronal sialic acid-containing gangliosides and to the glycoproteins RTN4R and RTN4RL2 (PubMed:7533044, PubMed:12089450, PubMed:27922006). Not required for initial myelination, but seems to play a role in the maintenance of normal axon myelination (PubMed:7516497, PubMed:9262180, PubMed:9482781, PubMed:9482783, PubMed:9469574, PubMed:10625334). Protects motoneurons against apoptosis, also after injury; protection against apoptosis is probably mediated via interaction with neuronal RTN4R and RTN4RL2 (PubMed:26335717). Required to prevent degeneration of myelinated axons in adults; this probably depends on binding to gangliosides on the axon cell membrane (PubMed:15953602, PubMed:19158290). Negative regulator of neurite outgrowth that inhibits axon longitudinal growth (PubMed:19158290, PubMed:27922006, PubMed:12089450). Negative regulator of neurite outgrowth; in dorsal root ganglion neurons the inhibition is mediated primarily via binding to neuronal RTN4R or RTN4RL2 and to a lesser degree via binding to neuronal gangliosides (PubMed:17640868). In cerebellar granule cells the inhibition is mediated via binding to neuronal gangliosides (PubMed:17640868). In sensory neurons, inhibition of neurite extension depends only partially on RTN4R, RTN4RL2 and gangliosides (By similarity). Inhibits axon outgrowth by binding to RTN4R (PubMed:12089450). Preferentially binds to alpha-2,3-linked sialic acid (PubMed:7533044, PubMed:27922006). Binds ganglioside Gt1b (PubMed:27922006).
    Show/Hide
Uniprot ID
Primary ID:
P20917

Secondarily ID:
A0A087WPR1
P16880
    Show/Hide
Ensembl ID
ENSG00000105695
Subcellular Location
Cell membrane
Membrane raft
Map of Molecular Bioactivity Related to the Protein
Map of Molecular Bioactivity Related to the Protein

Protein
Cell Line
Compound

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Protein
Cell Line ID: CL000942 , Lec3.2.8.1
Compound ID Compound Name Compound Formula
CP0905518
Sodium-((2,3-Difluorobenzyl)-5-Fluoroacetamido-9-(4-chlorobenzamido)-3,5,9-trideoxy-D-glycero-alpha-D-galacto-2-nonulopyranosid)onate
   Show/Hide
C25H25ClF3N2NaO9
 1
1
Kd = 500 nM
   TI
   LI
   LO
   TS
CP0926206
Sodium-((2,3-Difluorobenzyl)-5-(o-Nitrotoluenesulfonamido)-9-(4-chlorobenzamido)-3,5,9-trideoxy-D-glycero-alpha-D-galacto-2-nonulopyranosid)onate
   Show/Hide
C29H27ClF2N3NaO12S
 1
1
Kd = 1400 nM
   TI
   LI
   LO
   TS
CP0913197
Sodium-((2,3-Difluorobenzyl)-5-Chloroacetamido-9-(4-chlorobenzamido)-3,5,9-trideoxy-D-glycero-alpha-D-galacto-2-nonulopyranosid)onate
   Show/Hide
C25H25Cl2F2N2NaO9
 1
1
Kd = 2100 nM
   TI
   LI
   LO
   TS
CP0851756
Sodium-((2,3-Difluorobenzyl)-5-Methoxyacetamido-9-(4-chlorobenzamido)-3,5,9-trideoxy-D-glycero-alpha-D-galacto-2-nonulopyranosid)onate
   Show/Hide
C26H28ClF2N2NaO10
 1
1
Kd = 2300 nM
   TI
   LI
   LO
   TS
CP0851755
Sodium-(2,3-Difluorobenzyl-5-Acetamido-9-(4-chlorobenzamido)-3,5,9-trideoxy-D-glycero-alpha-D-galacto-2-nonulopyranosid)onate
   Show/Hide
C25H26ClF2N2NaO9
 1
1
Kd = 2400 nM
   TI
   LI
   LO
   TS
CP0924924
sodium-(2S,4S,5R,6R)-2-((2R,3R,4S,5S,6R)-2-((2R,3R,4R)-2-((biphenyl-4-ylmethoxy)methyl)-3-hydroxytetrahydro-2H-pyran-4-yloxy)-3,5-dihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-4-yloxy)-5-(carboxyamino)-6-((1R,2R)-3-(4-chlorobenzamido)-1,2-dihydroxypropyl)-4-hydroxytetrahydro-2H-pyran-2-carboxylate
   Show/Hide
C42H50ClN2NaO18
 1
1
Kd = 2830 nM
   TI
   LI
   LO
   TS
CP0879734
Sodium-((2,3-Difluorobenzyl)-5-Cyclopropylamido-9-(4-chlorobenzamido)-3,5,9-trideoxy-D-glycero-alpha-D-galacto-2-nonulopyranosid)onate
   Show/Hide
C28H30ClF2N2NaO9
 1
1
Kd = 4100 nM
   TI
   LI
   LO
   TS
CP0914692
Sodium-(2,3-Dichlorobenzyl 5-Acetamido-9-(4-chlorobenzamido)-3,5,9-trideoxy-D-glycero-alpha-D-galacto-2-nonulopyranosid)onate
   Show/Hide
C25H26Cl3N2NaO9
 1
1
Kd = 4300 nM
   TI
   LI
   LO
   TS
CP0868043
sodium-(2S,4S,5R,6R)-6-((1R,2R)-3-benzamido-1,2-dihydroxypropyl)-2-((2R,3R,4S,5S,6R)-2-((2R,3R,4R)-2-((biphenyl-4-ylmethoxy)methyl)-3-hydroxytetrahydro-2H-pyran-4-yloxy)-3,5-dihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-4-yloxy)-5-(carboxyamino)-4-hydroxytetrahydro-2H-pyran-2-carboxylate
   Show/Hide
C42H51N2NaO18
 1
1
Kd = 4440 nM
   TI
   LI
   LO
   TS
CP0918966
Sodium-((2,3-Difluorobenzyl)-5-Cyclobutylamido-9-(4-chlorobenzamido)-3,5,9-trideoxy-D-glycero-alpha-D-galacto-2-nonulopyranosid)onate
   Show/Hide
C29H32ClF2N2NaO9
 1
1
Kd = 5800 nM
   TI
   LI
   LO
   TS
CP0915457
Sodium-(Pentafluorobenzyl 5-Acetamido-9-(4-chlorobenzamido)-3,5,9-trideoxy-D-glycero-alpha-D-galacto-2-nonulopyranosid)onate
   Show/Hide
C25H23ClF5N2NaO9
 1
1
Kd = 6100 nM
   TI
   LI
   LO
   TS
CP0851754
Sodium-(2-Naphthyl 5-Acetamido-9-(4-chlorobenzamido)-3,5,9-trideoxy-D-glycero-alpha-D-galacto-2-nonulopyranosid)onate
   Show/Hide
C29H30ClN2NaO9
 1
1
Kd = 11600 nM
   TI
   LI
   LO
   TS
CP0872711
sodium-(2R,4S,5R,6R)-2-((1H-1,2,3-triazol-4-yl)methoxy)-5-acetamido-6-((1S,2R)-3-benzamido-1,2-dihydroxypropyl)-4-hydroxytetrahydro-2H-pyran-2-carboxylate
   Show/Hide
C21H26N5NaO9
 1
1
Kd = 11700 nM
   TI
   LI
   LO
   TS
CP0879733
Sodium-(4-Fluorobenzyl 5-Acetamido-9-(4-chlorobenzamido)-3,5,9-trideoxy-D-glycero-alpha-D-galacto-2-nonulopyranosid)onate
   Show/Hide
C25H27ClFN2NaO9
 1
1
Kd = 13000 nM
   TI
   LI
   LO
   TS
CP0868034
sodium (benzyl 5-acetamido-9-benzamido-3,5,9-trideoxy-D-glycero-a-D-galacto-2-nonulopyranosid)onate
   Show/Hide
C25H29N2NaO9
 6
1
Kd = 14900 nM
   TI
   LI
   LO
   TS
2
Kd = 17600 nM
   TI
   LI
   LO
   TS
3
Kd = 17800 nM
   TI
   LI
   LO
   TS
4
Kd = 20000 nM
   TI
   LI
   LO
   TS
5
Kd = 21800 nM
   TI
   LI
   LO
   TS
6
Kd = 26000 nM
   TI
   LI
   LO
   TS
CP0916400
Sodium-(4-Chlorobenzyl 5-Acetamido-9-(4-chlorobenzamido)-3,5,9-trideoxy-D-glycero-alpha-D-galacto-2-nonulopyranosid)onate
   Show/Hide
C25H27Cl2N2NaO9
 1
1
Kd = 15000 nM
   TI
   LI
   LO
   TS
CP0851753
sodium [benzyl 5-acetamido-9-(4-chlorobenzamido)-3,5,9-trideoxy-D-glycero-a-D-galacto-2-nonulopyranosid]onate
   Show/Hide
C25H28ClN2NaO9
 1
1
Kd = 17000 nM
   TI
   LI
   LO
   TS
CP0888531
Sodium-((2,3-Difluorobenzyl)-5-Methylsulfonamido-9-(4-chlorobenzamido)-3,5,9-trideoxy-D-glycero-alpha-D-galacto-2-nonulopyranosid)onate
   Show/Hide
C24H26ClF2N2NaO10S
 1
1
Kd = 17000 nM
   TI
   LI
   LO
   TS
CP0868037
sodium [benzyl 5-acetamido-9-(3,4-dichlorobenzamido)-3,5,9-trideoxy-D-glycero-a-D-galacto-2-nonulopyranosid]onate
   Show/Hide
C25H27Cl2N2NaO9
 1
1
Kd = 19200 nM
   TI
   LI
   LO
   TS
CP0921644
sodium [benzyl 5-acetamido-9-(3-chlorobenzamido)-3,5,9-trideoxy-D-glycero-a-D-galacto-2-nonulopyranosid]onate
   Show/Hide
C25H28ClN2NaO9
 1
1
Kd = 33900 nM
   TI
   LI
   LO
   TS
Similar Protein(s) and Bioactivity Statistics
90% Identity
Protein ID Protein Name Protein Organism
PT04165 Myelin-associated glycoprotein Homo sapiens, Human